September issue: The hype, peril, and promise of AI

Biosecurity

Mpox virus illustration.

Mpox is down but not out: Why a waning outbreak is no cause for complacency

By Matt Field, Dimie Ogoina | Biosecurity

The Pentagon.

Why the Pentagon should “surge” investments in pathogen early warning systems

By Christine Parthemore, Andrew Weber | Biosecurity

President Biden with Middle East leaders

Why a WMD-free zone in the Middle East is more needed than ever

By Almuntaser Albalawi | Biosecurity, Chemical Weapons, Nuclear Energy, Nuclear Weapons, Opinion, Voices of Tomorrow

There’s a ‘ChatGPT’ for biology. What could go wrong?

By Sean Ekins, Filippa Lentzos, Max Brackmann, Cédric Invernizzi | Biosecurity

A US national labs researcher studying viruses.

How to tell biodefense from an offensive bioweapons program

By Dan Regan, Rhys Dubin | Biosecurity

Watch the latest update on the labs studying the world’s most dangerous pathogens

By Erik English | Biosecurity

An anthrax-laced letter.

The Biden administration overestimates radiological terrorism risks and underplays biothreats

By Zachary Kallenborn | Biosecurity

The real horrors of ‘The Last of Us’ may already be here

By Erik English | Biosecurity

A House hearing on the origins of COVID.

A House subcommittee investigating COVID-19’s origins hears from a former CDC head and other prominent witnesses

By Matt Field | Biosecurity

Can a 1975 bioweapons ban handle today’s biothreats?

By Matt Field | Biosecurity

A covid test.

How to minimize COVID’s impacts once the federal emergency “ends”

By Lynn Klotz, Jonas Sandbrink | Biosecurity

One year of war in Ukraine

By Erik English | Biosecurity, Climate Change, Multimedia, Nuclear Risk